TABLE 3.
Antimicrobial susceptibilities of 53 initial CRKP strains
| Antibiotic(s) | No. (%) of patients with susceptible initial strain in group |
P value | |
|---|---|---|---|
| Case (n = 35) |
Control (n = 18) |
||
| Ceftazidime | 0 (0) | 0 (0) | |
| Cefepime | 1 (3) | 1 (6) | 1.000 |
| Piperacillin-tazobactam | 0 (0) | 0 (0) | |
| Ertapenem | 0 (0) | 0 (0) | |
| Imipenem | 0 (0) | 0 (0) | |
| Amikacin | 34 (97) | 16 (89) | 0.263 |
| Gentamicin | 19 (54) | 8 (44) | 0.497 |
| Ciprofloxacin | 0 (0) | 1 (6) | 0.340 |
| Levofloxacin | 0 (0) | 1 (6) | 0.340 |
| Tigecycline | 29 (83) | 13 (72) | 0.478 |
| Trimethoprim-sulfamethoxazole | 6 (17) | 5 (28) | 0.478 |